Lantech (Netherlands) Overview
- Founded
-
1983

- Status
-
Acquired/Merged
- Employees
-
40

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Lantech (Netherlands) General Information
Description
Provider of IT consulting and infrastructure services. The company offers comprehensive service ranging from design, implementation, maintenance to fully managed services and specializes in building and maintaining secure business networks in medium and large environments with customers in various segments such as government, education, logistics, healthcare and services.
Contact Information
Primary Industry
IT Consulting and Outsourcing
Acquirer
Primary Office
- Databankweg 26c
- 3821 AL Amersfoort
- Netherlands
+31 088 000 0000
Lantech (Netherlands) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Lantech (Netherlands) Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of IT consulting and infrastructure services. The company offers comprehensive service ranging from design, imp
IT Consulting and Outsourcing
Amersfoort, Netherlands
40
As of 2020
0.000
0000-00-00
000000000000
Lantech (Netherlands) Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000 0000000000 | Corporate Backed or Acquired | Extertal, Germany | 000000&0 |
Lantech (Netherlands) Patents
Lantech (Netherlands) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2014252584-A8 | Anti-angiogenesis compound, intermediate and use thereof | Active | 09-Apr-2013 | 0000000000 | |
AU-2014252584-A1 | Anti-angiogenesis compound, intermediate and use thereof | Active | 09-Apr-2013 | 0000000000 | |
AU-2014252584-B2 | Anti-angiogenesis compound, intermediate and use thereof | Active | 09-Apr-2013 | 0000000000 | |
CA-2908849-A1 | Anti-angiogenesis compound, intermediate and use thereof | Active | 09-Apr-2013 | 0000000000 | |
CA-2908849-C | Anti-angiogenesis compound, intermediate and use thereof | Active | 09-Apr-2013 | A61K31/519 |
Lantech (Netherlands) Signals
Lantech (Netherlands) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|